News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
156,097 Results
Type
Article (5850)
Company Profile (113)
Press Release (150133)
Multimedia
Podcasts (44)
Webinars (9)
Section
Business (52608)
Career Advice (160)
Deals (9249)
Drug Delivery (76)
Drug Development (21397)
Employer Resources (30)
FDA (3388)
Job Trends (3877)
News (84723)
Policy (6528)
Tag
2027 Genetown Standard (1)
Academia (406)
Accelerated approval (8)
Adcomms (8)
Allergies (48)
Alliances (6354)
ALS (56)
Alzheimer's disease (556)
Antibody-drug conjugate (ADC) (100)
Approvals (3524)
Artificial intelligence (109)
Autoimmune disease (38)
Automation (6)
Bankruptcy (64)
Best Places to Work (3537)
BIOSECURE Act (2)
Biosimilars (56)
Biotechnology (86)
Bladder cancer (68)
Brain cancer (17)
Breast cancer (224)
Cancer (1462)
Cardiovascular disease (121)
Career advice (136)
Career pathing (7)
CAR-T (79)
CDC (4)
Cell therapy (182)
Cervical cancer (13)
Clinical research (18934)
Collaboration (296)
Compensation (146)
Complete response letters (15)
COVID-19 (616)
CRISPR (29)
C-suite (83)
Cystic fibrosis (48)
Data (1967)
Denatured (15)
Depression (41)
Diabetes (106)
Diagnostics (1839)
Digital health (10)
Diversity (3)
Diversity, equity & inclusion (8)
Drug discovery (38)
Drug pricing (52)
Drug shortages (9)
Duchenne muscular dystrophy (51)
Earnings (41404)
Editorial (4)
Employer branding (3)
Employer resources (22)
Events (24510)
Executive appointments (96)
FDA (4377)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (225)
Gene editing (53)
Generative AI (8)
Gene therapy (142)
GLP-1 (314)
Government (912)
Grass and pollen (4)
Guidances (307)
Healthcare (4828)
HIV (21)
Huntington's disease (16)
IgA nephropathy (15)
Immunology and inflammation (45)
Immuno-oncology (11)
Indications (30)
Infectious disease (680)
Inflammatory bowel disease (58)
Inflation Reduction Act (7)
Influenza (18)
Intellectual property (43)
Interviews (17)
IPO (6116)
IRA (18)
Job creations (472)
Job search strategy (110)
JPM (12)
Kidney cancer (8)
Labor market (27)
Layoffs (91)
Leadership (1)
Legal (1065)
Liver cancer (29)
Longevity (2)
Lung cancer (246)
Lymphoma (142)
Machine learning (6)
Management (5)
Manufacturing (134)
MASH (57)
Medical device (3780)
Medtech (3793)
Mergers & acquisitions (3431)
Metabolic disorders (353)
Multiple sclerosis (50)
NASH (17)
Neurodegenerative disease (74)
Neuropsychiatric disorders (18)
Neuroscience (919)
NextGen: Class of 2026 (988)
Non-profit (730)
Now hiring (18)
Obesity (164)
Opinion (72)
Ovarian cancer (42)
Pain (40)
Pancreatic cancer (66)
Parkinson's disease (106)
Partnered (2)
Patents (72)
Patient recruitment (81)
Peanut (26)
People (7088)
Pharmaceutical (16)
Pharmacy benefit managers (3)
Phase 1 (5231)
Phase 2 (8255)
Phase 3 (7148)
Pipeline (2196)
Policy (45)
Postmarket research (632)
Preclinical (1670)
Press Release (24)
Prostate cancer (81)
Psychedelics (8)
Radiopharmaceuticals (161)
Rare diseases (209)
Real estate (744)
Recruiting (12)
Regulatory (5535)
Reports (19)
Research institute (427)
Resumes & cover letters (25)
Rett syndrome (16)
RNA editing (2)
RSV (27)
Schizophrenia (48)
Series A (39)
Series B (31)
Service/supplier (5)
Sickle cell disease (27)
Special edition (10)
Spinal muscular atrophy (40)
Sponsored (10)
Startups (392)
Stomach cancer (4)
Supply chain (15)
Tariffs (7)
The Weekly (28)
Vaccines (199)
Venture capital (15)
Weight loss (137)
Women's health (25)
Worklife (9)
Date
Last 7 days (132)
Last 30 days (538)
Last 365 days (8536)
2026 (631)
2025 (8685)
2024 (19207)
2023 (20278)
2022 (11223)
2021 (11228)
2020 (10570)
2019 (8936)
2018 (6556)
2017 (6437)
2016 (5526)
2015 (6812)
2014 (4604)
2013 (3252)
2012 (3516)
2011 (4454)
2010 (4043)
Location
Africa (108)
Alabama (29)
Alaska (3)
Arizona (68)
Arkansas (5)
Asia (9652)
Australia (1429)
California (2960)
Canada (1135)
China (284)
Colorado (167)
Connecticut (143)
Delaware (117)
Europe (21592)
Florida (435)
Georgia (95)
Hawaii (2)
Idaho (25)
Illinois (220)
India (26)
Indiana (198)
Iowa (2)
Japan (155)
Kansas (35)
Kentucky (10)
Louisiana (12)
Maine (33)
Maryland (401)
Massachusetts (2537)
Michigan (168)
Minnesota (254)
Mississippi (1)
Missouri (40)
Montana (19)
Nebraska (10)
Nevada (35)
New Hampshire (46)
New Jersey (1124)
New Mexico (11)
New York (872)
North Carolina (627)
North Dakota (6)
Northern California (1429)
Ohio (91)
Oklahoma (5)
Oregon (19)
Pennsylvania (739)
Puerto Rico (2)
Rhode Island (8)
South America (180)
South Carolina (6)
Southern California (1188)
Tennessee (34)
Texas (538)
United States (12356)
Utah (149)
Virginia (54)
Washington D.C. (13)
Washington State (329)
Wisconsin (31)
156,097 Results for "28".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
McKesson Corporation Declares Quarterly Dividend - January 28, 2026
January 29, 2026
·
1 min read
Press Releases
STERIS Announces Dividend of $0.63 per share - January 28, 2026
January 29, 2026
·
4 min read
Press Releases
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
January 20, 2026
·
2 min read
Press Releases
GenSight Biologics Announces the Results of its Extraordinary General Meeting of January 28, 2026
January 29, 2026
·
2 min read
Press Releases
Clene Announces Registered Direct Offering of Over $28 Million
January 9, 2026
·
10 min read
Press Releases
MustGrow Announces Record Q2-2025 Results: $2.8 Million Revenue and 20.9% Gross Profit Margin for the Quarter
Investor Webcast: Thursday, August 28th at 4:00pm ET / 1:00pm PT
August 28, 2025
·
5 min read
Press Releases
Axol Bioscience Raises $2.8M to Advance US Expansion and Product Development
January 14, 2026
·
2 min read
Press Releases
Annovis to Host Corporate Update Webinar on January 28, 2026
December 17, 2025
·
2 min read
Press Releases
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
January 27, 2026
·
5 min read
Press Releases
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 28, 2026
January 29, 2026
·
1 min read
1 of 15,610
Next
